IOL CHEMICALS & PHARM. | DISHMAN CARBOGEN AMCIS | IOL CHEMICALS & PHARM./ DISHMAN CARBOGEN AMCIS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 12.4 | -23.9 | - | View Chart |
P/BV | x | 1.4 | 0.6 | 221.4% | View Chart |
Dividend Yield | % | 1.1 | 0.0 | - |
IOL CHEMICALS & PHARM. DISHMAN CARBOGEN AMCIS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
DISHMAN CARBOGEN AMCIS Mar-23 |
IOL CHEMICALS & PHARM./ DISHMAN CARBOGEN AMCIS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 201 | 266.6% | |
Low | Rs | 272 | 80 | 340.0% | |
Sales per share (Unadj.) | Rs | 377.6 | 153.9 | 245.4% | |
Earnings per share (Unadj.) | Rs | 23.7 | -1.9 | -1,246.9% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 16.0 | 197.2% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 370.6 | 69.3% | |
Shares outstanding (eoy) | m | 58.71 | 156.78 | 37.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.9 | 117.1% | |
Avg P/E ratio | x | 17.1 | -74.0 | -23.1% | |
P/CF ratio (eoy) | x | 12.8 | 8.8 | 145.8% | |
Price / Book Value ratio | x | 1.6 | 0.4 | 414.7% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 22,059 | 107.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 10,353 | 16.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 24,129 | 91.9% | |
Other income | Rs m | 256 | 278 | 92.2% | |
Total revenues | Rs m | 22,427 | 24,407 | 91.9% | |
Gross profit | Rs m | 2,257 | 2,841 | 79.4% | |
Depreciation | Rs m | 462 | 2,807 | 16.4% | |
Interest | Rs m | 165 | 857 | 19.2% | |
Profit before tax | Rs m | 1,887 | -546 | -345.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | -248 | -199.7% | |
Profit after tax | Rs m | 1,391 | -298 | -466.9% | |
Gross profit margin | % | 10.2 | 11.8 | 86.5% | |
Effective tax rate | % | 26.2 | 45.4 | 57.8% | |
Net profit margin | % | 6.3 | -1.2 | -508.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 19,184 | 50.4% | |
Current liabilities | Rs m | 5,025 | 17,984 | 27.9% | |
Net working cap to sales | % | 20.9 | 5.0 | 421.0% | |
Current ratio | x | 1.9 | 1.1 | 180.3% | |
Inventory Days | Days | 43 | 71 | 61.2% | |
Debtors Days | Days | 8 | 9 | 93.2% | |
Net fixed assets | Rs m | 11,017 | 75,211 | 14.6% | |
Share capital | Rs m | 587 | 314 | 187.2% | |
"Free" reserves | Rs m | 14,490 | 57,783 | 25.1% | |
Net worth | Rs m | 15,077 | 58,097 | 26.0% | |
Long term debt | Rs m | 0 | 10,467 | 0.0% | |
Total assets | Rs m | 20,684 | 94,395 | 21.9% | |
Interest coverage | x | 12.5 | 0.4 | 3,431.5% | |
Debt to equity ratio | x | 0 | 0.2 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.3 | 419.3% | |
Return on assets | % | 7.5 | 0.6 | 1,270.6% | |
Return on equity | % | 9.2 | -0.5 | -1,799.1% | |
Return on capital | % | 13.6 | 0.5 | 2,999.3% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 3,980 | 149.0% | |
Fx outflow | Rs m | 6,052 | 761 | 795.1% | |
Net fx | Rs m | -122 | 3,219 | -3.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 2,203 | 55.5% | |
From Investments | Rs m | -1,200 | -4,485 | 26.8% | |
From Financial Activity | Rs m | -41 | 2,497 | -1.6% | |
Net Cashflow | Rs m | -18 | 216 | -8.5% |
Indian Promoters | % | 48.2 | 59.3 | 81.2% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 2.5 | 12.3 | 20.7% | |
FIIs | % | 2.2 | 8.6 | 25.3% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 40.7 | 127.4% | |
Shareholders | 134,235 | 52,336 | 256.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: SUN PHARMA DIVIS LABORATORIES CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | DISHMAN CARBOGEN AMCIS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.31% | 0.73% | 1.18% |
1-Month | -9.26% | -5.70% | -0.75% |
1-Year | 29.97% | 89.09% | 61.82% |
3-Year CAGR | -13.41% | 29.43% | 18.16% |
5-Year CAGR | 13.41% | 2.43% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the DISHMAN CARBOGEN AMCIS share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of DISHMAN CARBOGEN AMCIS the stake stands at 59.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of DISHMAN CARBOGEN AMCIS.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
DISHMAN CARBOGEN AMCIS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of DISHMAN CARBOGEN AMCIS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.